rethinkTHC Search
Menu
Study breakdown

Cannabis May Help HIV Patients Cope With Pain Impact, Not Pain Itself

evidence
The takeaway

Daily cannabis use attenuated the relationship between pain severity and pain interference in people with HIV, suggesting cannabis helps manage pain impact rather than reducing pain directly.

HIV clinicians, pain researchers, and medical cannabis scientists.

AMD +0.05 vs +1.13

pain interference per pain point increase for daily cannabis users vs. non-users, suggesting attenuated pain impact

What the researchers found

Cannabis use frequency was not directly associated with pain interference. However, daily cannabis use attenuated the pain severity-pain interference relationship (AMD +0.05 per pain point increase vs. +1.13 for non-users, p=0.049).

Why it matters

This distinction between reducing pain versus reducing pain impact on daily functioning offers a more nuanced understanding of how cannabis may benefit chronic pain patients.

The numbers in context

134 PWH with substance dependence/injection drug use history. Daily users: AMD +0.05 per pain point. 15-day users: +0.81. Non-users: +1.13. Interaction p=0.049.

How the study worked

Multi-variable linear regression with interaction term between cannabis use frequency and pain severity, analyzing pain interference as the outcome in PWH.

Who was studied

134 people with HIV who had substance dependence or lifetime injection drug use history.

What this study cannot tell us

Small sample (n=134). Cross-sectional design. Participants had substance dependence history, limiting generalizability. Cannabis use self-reported. Borderline significance (p=0.049).

How to read the evidence

Small cross-sectional study with borderline significant interaction; preliminary finding needing replication.

When this study was published

Recent analysis of pain dynamics in PWH.

The bigger picture

This nuanced finding suggests cannabis may work not by reducing pain sensation but by changing how much pain disrupts daily life, which is arguably the more clinically important outcome.

Replication

Small sample with borderline significance; larger replication needed.

Funding

Not specified in abstract

Conflicts of interest

Not specified in abstract

Questions still open

  • Is this attenuating effect specific to cannabis or would other substances show similar patterns?
  • Does this mechanism explain inconsistent cannabis pain trial results?

Read the original research

Cannabis use frequency and pain interference among people with HIV.

AIDS care, 35(8), 1235-1242

Citation

Klepp, T D; Heeren, T C; Winter, M R; Lloyd-Travaglini, C A; Magane, K M; Romero-Rodríguez, E; Kim, T W; Walley, A Y; Mason, T; Saitz, R. (2023). Cannabis use frequency and pain interference among people with HIV.. AIDS care, 35(8), 1235-1242. https://doi.org/10.1080/09540121.2023.2208321